NBTX
Income statement / Annual
Last year (2024), Nanobiotix S.A.'s total revenue was -$11.61 M,
a decrease of 132.06% from the previous year.
In 2024, Nanobiotix S.A.'s net income was -$68.13 M.
See Nanobiotix S.A.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
-$11.61 M |
$36.21 M |
$4.78 M |
$10.00 K |
$50.00 K |
$68.00 K |
$116.00 K |
$251.97 K |
$1.56 M |
$265.54 K |
Cost of Revenue |
$0.00
|
$0.00
|
$985.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$345.59 K
|
$436.31 K
|
$359.61 K
|
Gross Profit |
-$11.61 M
|
$36.21 M
|
$3.79 M
|
$10.00 K
|
$50.00 K
|
$68.00 K
|
$116.00 K
|
-$93.62 K
|
$1.12 M
|
-$94.07 K
|
Gross Profit Ratio |
1
|
1
|
0.79
|
1
|
1
|
1
|
1
|
-0.37
|
0.72
|
-0.35
|
Research and Development Expenses |
$40.54 M
|
$38.40 M
|
$32.64 M
|
$30.38 M
|
$24.33 M
|
$30.41 M
|
$20.89 M
|
$16.34 M
|
$16.92 M
|
$13.90 M
|
General & Administrative Expenses |
$20.06 M
|
$21.66 M
|
$17.48 M
|
$19.43 M
|
$14.27 M
|
$18.64 M
|
$12.62 M
|
$12.34 M
|
$10.26 M
|
$7.19 M
|
Selling & Marketing Expenses |
$0.00
|
$388.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$20.06 M
|
$22.05 M
|
$17.48 M
|
$19.43 M
|
$14.27 M
|
$18.64 M
|
$12.62 M
|
$12.34 M
|
$10.26 M
|
$7.19 M
|
Other Expenses |
-$3.82 M
|
$2.54 M
|
-$3.41 M
|
-$2.64 M
|
-$2.07 M
|
-$2.20 M
|
-$3.33 M
|
-$337.89 K
|
$160.23 K
|
$0.00
|
Operating Expenses |
$56.78 M
|
$62.99 M
|
$46.70 M
|
$47.18 M
|
$36.53 M
|
$46.85 M
|
$30.18 M
|
$25.52 M
|
$23.41 M
|
$17.41 M
|
Cost And Expenses |
$56.78 M
|
$62.99 M
|
$46.70 M
|
$47.18 M
|
$36.53 M
|
$46.85 M
|
$30.18 M
|
$25.52 M
|
$23.41 M
|
$17.41 M
|
Interest Income |
$2.63 M
|
$1.22 M
|
$256.00 K
|
$6.17 M
|
$4.68 M
|
$105.00 K
|
$34.00 K
|
$33.03 K
|
$59.49 K
|
$183.22 K
|
Interest Expense |
$8.09 M
|
$7.98 M
|
$5.84 M
|
$590.00 K
|
$333.00 K
|
$4.79 M
|
$847.00 K
|
$108.37 K
|
$102.20 K
|
$59.52 K
|
Depreciation & Amortization |
$1.62 M
|
$551.00 K
|
$1.50 M
|
$1.56 M
|
$1.76 M
|
$1.77 M
|
$569.00 K
|
$345.59 K
|
$436.31 K
|
$456.08 K
|
EBITDA |
-$58.32 M |
-$23.69 M |
-$45.15 M |
-$45.61 M |
-$31.49 M |
-$44.78 M |
-$29.33 M |
-$25.55 M |
-$21.21 M |
-$16.49 M |
EBITDA Ratio |
5.02
|
-0.65
|
-9.45
|
-4560.5
|
-629.88
|
-658.46
|
-252.83
|
-101.39
|
-13.61
|
-62.09
|
Operating Income Ratio |
5.89
|
-0.74
|
-9.78
|
-5257.9
|
-728.56
|
-687.93
|
-259.2
|
-100.28
|
-14.03
|
-64.55
|
Total Other Income/Expenses Net |
$361.00 K
|
-$12.80 M
|
-$10.33 M
|
$5.58 M
|
$2.85 M
|
-$4.13 M
|
-$278.00 K
|
-$876.00 K
|
$64.61 K
|
$138.56 K
|
Income Before Tax |
-$68.03 M
|
-$39.58 M
|
-$57.03 M
|
-$47.00 M
|
-$33.61 M
|
-$50.91 M
|
-$30.35 M
|
-$26.14 M
|
-$21.79 M
|
-$17.00 M
|
Income Before Tax Ratio |
5.86
|
-1.09
|
-11.94
|
-4699.9
|
-672.28
|
-748.71
|
-261.59
|
-103.76
|
-13.99
|
-64.03
|
Income Tax Expense |
$101.00 K
|
$120.00 K
|
$10.00 K
|
$5.00 K
|
$9.00 K
|
$3.00 K
|
-$449.00 K
|
$20.00
|
$90.43 K
|
$37.58 K
|
Net Income |
-$68.13 M
|
-$39.70 M
|
-$57.04 M
|
-$47.00 M
|
-$33.62 M
|
-$50.92 M
|
-$29.90 M
|
-$26.14 M
|
-$21.88 M
|
-$17.00 M
|
Net Income Ratio |
5.87
|
-1.1
|
-11.94
|
-4700.4
|
-672.46
|
-748.75
|
-257.72
|
-103.76
|
-14.04
|
-64.03
|
EPS |
-1.44 |
-1.08 |
-1.64 |
-1.35 |
-1.38 |
-2.35 |
-1.52 |
-1.5 |
-1.43 |
-1.2 |
EPS Diluted |
-1.44 |
-1.08 |
-1.64 |
-1.35 |
-1.38 |
-2.35 |
-1.52 |
-1.5 |
-1.43 |
-1.2 |
Weighted Average Shares Out |
$47.27 M
|
$36.76 M
|
$34.85 M
|
$34.73 M
|
$24.39 M
|
$21.63 M
|
$19.62 M
|
$17.43 M
|
$15.28 M
|
$14.14 M
|
Weighted Average Shares Out Diluted |
$47.27 M
|
$36.93 M
|
$34.85 M
|
$34.73 M
|
$24.39 M
|
$21.63 M
|
$19.63 M
|
$17.48 M
|
$15.28 M
|
$14.14 M
|
Link |
|
|
|
|
|
|
|
|
|
|